IFNA1 and infection: One of the cell lines, DBTRG-05MG, was found to demonstrate a strong response to IFN-a treatment, which completely protected the cells from infection with vesicular stomatitis Indiana virus (VSV), while the A-172 GBM cell line retained high sensitivity to the virus regardless of the IFN treatment.